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Abstract
Treatment of emotional disorders involves the promotion of extinction processes, which are defined
as the learned reduction of fear. The molecular mechanisms underlying extinction have only begun
to be elucidated. By employing genetic and pharmacological approaches in mice, we show here that
extinction requires downregulation of Rac-1 and cyclin-dependent kinase 5 (Cdk5), and upregulation
of p21 activated kinase-1 (PAK-1) activity. This is physiologically achieved by a Rac-1–dependent
relocation of the Cdk5 activator p35 from the membrane to the cytosol and dissociation of p35 from
PAK-1. Moreover, our data suggest that Cdk5/p35 activity prevents extinction in part by inhibition
of PAK-1 activity in a Rac-1–dependent manner. We propose that extinction of contextual fear is
regulated by counteracting components of a molecular pathway involving Rac-1, Cdk5 and PAK-1.
Our data suggest that this pathway could provide a suitable target for therapeutic treatment of
emotional disorders.
The pathogenesis of emotional disorders, post-traumatic stress disorders in particular, often
involves associative learning that links anxiogenic stimuli to certain life experiences1–4. These
disorders severely affect the lives of patients and are an increasing burden on our societies1.
Treatment of such disorders generally involves the promotion of extinction processes, which
are defined as the reduction of an aversively-motivated behavior2. Therefore, understanding
the molecular mechanisms underlying extinction may help to develop therapeutic strategies
for emotional disorders.
A well-established procedure for investigating extinction in rodents is Pavlovian fear
conditioning. In this procedure, a single exposure of rodents to a novel context followed by an
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electric foot shock elicits the acquisition of conditioned fear. On the basis of associative
learning, the animals show an inborn aversive freezing behavior upon re-exposure to the
conditioned context. This form of contextual fear conditioning is hippocampus dependent and
leads to a long-lasting fear memory5. During extinction, animals are repeatedly re-exposed to
the conditioned context without receiving the foot shock again (extinction trial), which
eventually results in the decline of the aversive freezing behavior6.
At present, the molecular mechanisms underlying extinction are not well understood. A number
of studies have shown that some, but not all, components of the molecular machinery that is
required for the initial encoding of fear memories also regulate extinction7–10. Recent studies
indicate that synaptic remodeling, for example, mediated by actin re-arrangement, may be
important for extinction3,6. Actin dynamics are intimately involved in synaptic plasticity,
synapse formation and neuronal morphology6,11,12. Notably, Cdk5 has been described as an
important regulator of synaptic function and actin dynamics13–16.
Cdk5 is a serine/threonine protein-kinase that is critical for the development of the central
nervous system17. The related neuron-specific proteins p35 and p39 are required and sufficient
to activate Cdk5 on direct binding14. Recently, there has been emerging evidence for a role of
Cdk5/p35 in the adult brain. Cdk5 phosphorylates a number of synaptic proteins and regulates
dendritic spine morphogenesis, synaptic plasticity and learning18–26. Cdk5 regulates actin
dynamics via its upstream regulator Rac-1 and downstream target PAK-1, which have both
also been implicated in synaptic plasticity15,27,28. Whether a Cdk5 regulated pathway is
implicated with extinction of learned fear has not been addressed previously.
In this study, we show that inhibition of Cdk5 in the hippocampus facilitates extinction of
learned contextual fear. Conversely, extinction was severely impaired when Cdk5 activity was
upregulated. During physiological extinction, Cdk5 activity was downregulated by a reduced
membrane association of p35 via the small GTPase Rac-1. Furthermore, our data suggests that
inhibition of PAK-1 activity by Cdk5 impedes extinction.
RESULTS
Inhibition of Cdk5 activity facilitates extinction
To test whether Cdk5 activity has a role in extinction of learned fear, we implanted mice with
microcannula into the dorsal hippocampus (intrahippocampal; Supplementary Fig. 1 online)
and trained in the contextual fear-conditioning procedure. Fear conditioning consisted of a 3-
min context exposure followed by a single electric foot shock (0.7 mA, constant current, 2 s).
Subsequently, all mice were subjected to a daily extinction trial on 6 consecutive d (E1–E6).
Each extinction trial consisted of a 3 min re-exposure to the conditioned context without
presenting the foot shock again. It was previously shown that in this extinction procedure, mice
usually show a substantial reduction of aversive freezing behavior in 4–6 extinction trials that
are performed on consecutive days6.
Immediately after the exposure to E1–E3, mice were injected (intrahippocampal) with either
vehicle or three different concentrations of the Cdk5 inhibitor butyrolactone I. Injection of 50
ng of butyrolactone 1 significantly reduced freezing behavior on E2 and E3 when compared
with the vehicle group (P < 0.05, Fig. 1a). A reminder shock procedure6 was able to reinstate
freezing behavior, suggesting that the original fear memory was not entirely erased
(Supplementary Fig. 2 online). In agreement with previous data, the recovery of the fear
response was rarely complete and may indicate that unlearning and new learning may coexist
during extinction29,30. The injection of lower concentrations of butyrolactone 1 (25 or 12.5
ng) did not reduce hippocampal Cdk5 activity, as measured by histone H1 phosphorylation
(Supplementary Fig. 2), and had no significant effect on the reduction of freezing behavior
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(P = 0.3781, Fig. 1b,c). Notably, injection of roscovitine (intrahippocampal, 50 ng), another
well-established Cdk5 inhibitor, into the dorsal hippocampus immediately after E1–E3 also
reduced freezing behavior when compared with a vehicle group (Supplementary Fig. 2).
Consistent with the data presented in Figure 1a, a single injection of butyrolactone I (50 ng)
immediately after E1 significantly diminished freezing behavior in the subsequent extinction
trials when compared with the vehicle group (P < 0.0001, Fig. 1d). Similar results were obtained
when mice were injected 1 h after E1 (Fig. 1e). In contrast, when butyrolactone I (50 ng) was
administered 3 h after E1, freezing behavior was indistinguishable between butyrolactone I–
and vehicle-injected mice (Fig. 1f). We estimated that the employed concentrations of
butyrolactone I and roscovitine permit a specific inhibition of Cdk5. However, higher levels
of those drugs may also affect Erk-1/2 kinases31. Notably, injection of butyrolactone I (50 ng)
into the hippocampus did not affect the MAP kinase signaling pathway, which is important for
extinction of contextual fear9,32 (Supplementary Fig. 2). Furthermore, intrahippocampal
injection of butyrolactone I did not affect extinction of amygdala-dependent cued fear,
demonstrating that Cdk5 inhibition in the hippocampus has a specific effect on contextual fear.
Moreover, freezing behavior was not generally affected. (Supplementary Fig. 2). In addition,
we found that intrahippocampal injection of butyrolactone I 15 min before E1 or E2 did not
affect freezing behavior during the extinction trial, suggesting that Cdk5 activity affects the
consolidation of extinction in our procedure (Supplementary Fig. 2).
In summary, these data show that inhibition of hippocampal Cdk5 facilitates extinction of
aversive freezing behavior. Furthermore, our findings suggest that Cdk5 activity is critically
involved in regulating extinction within an interval of 1 h after exposure to the extinction trial.
Increased Cdk5 activity impairs extinction
We next investigated the effect of increased Cdk5 activity on extinction. To this end we
employed the CK-p25 Tg transgenic mice, in which forebrain-specific expression of the potent
Cdk5 activator p25 can be switched on and off by a doxycycline diet (Supplementary Fig. 3
online)19. We previously showed that expression of p25 for 1–2 weeks increased Cdk5 activity
in the hippocampus without causing any neuronal loss19. Here we subjected CK-p25 Tg and
control mice to contextual fear conditioning. p25 expression was induced 24 h later for 1 week
(Fig. 2a,b), which led to increased hippocampal Cdk5 activity (Fig. 2c). At this time point mice
were subjected to six consecutive extinction trials (Fig. 2a). In contrast to control mice, no
reduction of freezing behavior was observed in CK-p25 Tg mice (Fig. 2d). Next, doxycycline
was re-introduced to the diet, leading to the repression of p25 expression (Fig. 2b).
Consistently, hippocampal Cdk5 activity declined to baseline levels when measured 1 week
later (Fig. 2c; see 1 week On 1 week Off group). Subsequently, all mice were exposed to five
additional extinction trials. Notably, the 1 week ON 1 week OFF CK-p25 Tg showed a
significant reduction in freezing behavior (P < 0.0001, Fig. 2d). Thus, increased Cdk5 activity
prevented extinction, which can be reversed on downregulation of Cdk5 activity to baseline
levels. These observations suggest that Cdk5 activity negatively regulates extinction.
Extinction depletes Cdk5 activity from the membranes
To gain further insight into the mechanisms by which Cdk5 regulates extinction, we measured
Cdk5 and p35 levels during extinction. To this end, we compared E1 versus E3, because in our
procedure the molecular mechanisms activated after E1 (mice showed no extinction during
subsequent E2) versus E3 (mice showed extinction during subsequent E4) might be different.
Because we previously observed that Cdk5 activity was required for extinction within 1 h after
an extinction trial (see Fig. 1d–f), we focused the molecular analysis on the time point 0.5 h
after an extinction trial.
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Immunoblot analysis of total-protein lysates prepared from the hippocampus 0.5 h after E1,
E3 or from naive mice revealed no significant difference in p35 and Cdk5 levels (P = 0.2982,
Supplementary Fig. 4 online). We next examined the subcellular distribution of Cdk5 and p35
during extinction. Hippocampal lysates were prepared 0.5 h after E1 and E3 and from naive
animals, and were separated into membrane and nonmembrane fractions (Supplementary Fig.
4). Notably, we found that membrane-associated p35 levels were significantly reduced after
E3 when compared with E1 (P < 0.05, Fig. 3a).
Notably, when mice were exposed to E1, and hippocampal protein lysates were prepared 2 d
later without any further extinction trial, Cdk5 and p35 protein levels and distribution were not
affected (Supplementary Fig. 5), suggesting that membrane depletion of p35 is specific to
extinction. Taken together, these data show that the reduced freezing behavior during extinction
correlates with a reduction of membrane-associated p35 levels.
Rac-1 regulates the localization of Cdk5/p35 kinase and extinction
The small GTPase Rac-1 was shown to regulate the localization and activity of Cdk5/p35
kinase during neurite outgrowth33. This prompted us to investigate the involvement of Rac-1
in Cdk5-mediated extinction. Rac-1 is only active in its GTP-bound form (GTP–Rac-1)34. By
employing a Rac-1–activity assay (Upstate) we found that Rac-1 activity was markedly reduced
in membrane fraction after E3 when compared with the naive group (Fig. 3b). Total-protein
levels of Rac-1 were not significantly different between naive and E3 (P = 0.2561,
Supplementary Fig. 4), suggesting that membrane-associated Rac-1 activity decreased after
E1. The correlation between reduction of membrane-associated Rac-1 activity and p35 levels
after E3 prompted us to test the possibility of a direct relationship of Rac-1 activity and p35
localization during extinction.
We implanted microcannula into the lateral ventricles of mice that were subsequently trained
by contextual fear conditioning and exposed to our extinction procedure. Immediately after
E1–E3, mice were injected with a Rac-1 inhibitor35(NSC23760, 10 μg μl−1) or vehicle.
Hippocampal membrane and cytosolic fractions were prepared 0.5 h after E3 and analyzed by
immunoblot. When compared to the lysates prepared from the vehicle-injected group, mice
that were administered with the Rac-1 inhibitor showed a marked redistribution of membrane-
associated p35 and Cdk5 to the cytosol (Fig. 3c). This result suggests that Rac-1 activity
regulates the distribution of p35/Cdk5 kinase during extinction.
Next we wanted to determine the effect of Rac-1 on extinction directly. Microcannula were
implanted into the lateral ventricles of mice that were subsequently trained by contextual fear
conditioning and exposed to our extinction procedure. Immediately after E1–E3, mice were
injected with a Rac-1 inhibitor (NSC23760, 10 μg μl−1) or vehicle. Notably, mice injected with
the Rac-1 inhibitor showed facilitated extinction as indicated by a significant reduction of
freezing behavior when compared with the vehicle group (P < 0.0001, Fig. 3d). Similar results
were obtained by intrahippocampal injections (Supplementary Fig. 6 online). Thus, although
it is difficult to directly compare the effects of butyrolactone I and Rac-I inhibitors on the
dynamics of extinction in absolute terms, Rac-1 activity, similar to Cdk5, appears to inhibit
extinction.
A Rac-1–Cdk5–PAK-1 pathway regulates extinction
The Cdk5/p35 kinase was previously shown to regulate PAK-1 in a Rac-1–dependent
manner33,36. As PAK-1 is implicated in the dynamics of actin cytoskeleton, learning and
synaptic remodeling in the adult brain28, we sought to examine whether PAK-1 has a role in
Cdk5-mediated extinction.
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First, we measured PAK-1 phosphorylation at threonine 212 during extinction, as this site is
phosphorylated by the p35/Cdk5 kinase (ref. 33). We found that PAK-1T212 levels were
markedly reduced in the E3 membrane fraction when compared with naive mice or E1 (Fig.
4a). These data are consistent with decreased membrane-associated p35 levels observed after
E3 (see Fig. 3a) and further support the view that Cdk5 activity declines during extinction. We
also analyzed the activity of PAK-1 using a phospho-T423 antibody to PAK-1 (ref. 37) in
hippocampal lysates prepared from naive mice and from mice 0.5 h after E1 or E3 by
immunoblotting. We detected a significant increase in membrane-associated PAK-1Thr423
levels after E3, when compared with E1 (P < 0.05, Fig. 4b). In the cytosolic fraction,
PAK-1Thr423 levels were downregulated after E1 when compared with naive mice, and
increased after E3 when compared with E1 (Fig. 4b). These data suggest that the activity of
PAK-1 is upregulated during extinction.
Next, we set out to determine if the regulation of PAK-1 activity during extinction depended
on the activities of Rac-1 and the Cdk5/p35 kinase. To this end, we analyzed lysates prepared
from mice that were injected with a Rac-1 inhibitor or vehicle (as described in Fig. 3c) by
immunoblot. When compared with the vehicle-injected group, mice that were administered
with the Rac-1 inhibitor showed a substantial reduction of membrane-associated PAK-1 and
PAK-1T212 levels (Fig. 4c). Consistently, PAK-1 levels increased in the cytosol of mice treated
with Rac-1 inhibitor. However, we observed no corresponding increase in p-PAK-1T212 levels
in the cytosol. In fact, cytosolic PAK-1T212 levels were also decreased (Fig. 4c). On co-
immunoprecipitation of PAK-1 and p35 from cytosolic fractions, we found that Rac-1 inhibitor
treatment resulted in a reduced amount of p35 being co-immunoprecipitated with PAK-1 when
compared with the vehicle group (Fig. 4d). This result suggests that cytosolic p35 is sequestered
from PAK-1 on Rac-1 inhibition during extinction. In summary, these data suggest that Rac-1
activity regulates PAK-1 during extinction.
To investigate the impact of Cdk5/p35 kinase activity on PAK-1 function during extinction,
we implanted mice with microcannula in the lateral ventricles and injected them with 50 ng of
butyrolactone I immediately after E1. Because a single injection of butyrolactone I after E1
was sufficient to facilitate extinction (see Fig. 1d), we prepared hippocampal lysates 0.5 h after
E1 and analyzed them by immunoblotting using PAK-1 antibodies (P < 0.05, Fig. 5a).
Butyrolactone I injection significantly reduced Cdk5-dependent phosphorylation of PAK-1,
as PAK-1T212 levels in both the membrane and cytosolic fractions were decreased (Fig. 5b,c).
In contrast, PAK-1T423 levels increased in lysates obtained from butyrolactone I–injected mice
(Fig. 5b,c). Moreover, similar to treatment with Rac-1 inhibitor, inhibition of Cdk5 caused a
redistribution of total PAK-1 from the membrane to the cytosol (Fig. 5d). These data provide
evidence that Rac-1 and Cdk5/p35 kinase regulate the activity of PAK-1 during extinction.
PAK-1 promotes extinction
To further determine a role for PAK-1 activity during extinction, we introduced a herpes virus
expressing green fluorescent protein (GFP) and a dominant-negative PAK-1 (HSV–dnPAK-1)
into the dorsal hippocampus via a microcannula. It was previously shown that the dnPAK-1
protein substantially inhibited Pak-1 activity in vivo28. It is important that mice first normally
acquire fear memories, and that any molecular manipulation is only applied after the extinction
trial. To this end, we first subjected mice to contextual fear conditioning. After 24 h, HSV–
dnPAK-1 or HSV-GFP (control group) was injected into the hippocampus. Because we found
in pilot experiments that expression of these constructs (as measured by GFP signal) was first
detectable 1 d after injection (Fig. 6), all mice were subjected to extinction trials the next day
(Fig. 6a). Notably, we found that mice injected with HSV–dnPAK-1 showed a significant
impairment in extinction when compared with the control group (P < 0.05, Fig. 6c). These data
suggest that inhibition of PAK-1 activity impairs extinction.
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DISCUSSION
In this study, we show that pharmacological inhibition of hippocampal Cdk5 activity by
butyrolactone I or roscovitine facilitates extinction in the contextual fear-conditioning
procedure. Conversely, increased Cdk5 activity in CK-p25 Tg mice severely impaired
extinction, as indicated by the persistence of aversive freezing behavior. Therefore, our data
suggest that although Cdk5 activity seems to be important for the initial encoding of the
contextual fear memory trace18, it subsequently impairs contextual fear extinction. Notably,
similar observations have been made for cAMP signaling. To this end, cAMP is required for
the acquisition of fear memory38, but mice that overexpress the type I adenylyl cyclase Adcy1
in the forebrain and that have elevated hippocampal cAMP levels show slower extinction of
fear39.
Besides the hippocampus, the prefrontal cortex and the amygdala have been implicated with
the extinction of cued and contextual fear4,40–42. The possible role of Cdk5 activity in those
brain areas during extinction is a question that remains unanswered.
To elucidate the molecular mechanism by which Cdk5 activity regulates extinction, we took
advantage of the employed experimental extinction procedure. As such, after a single fear-
conditioning training mice showed freezing behavior on E1–E3. When retested on E4,
however, freezing was usually substantially decreased. We therefore speculated that the key
molecular processes triggered after E1 (mice showed freezing on subsequent E2) and E3 (mice
showed reduced freezing on subsequent E4) are different.
Notably, we observed a redistribution of membrane-associated hippocampal p35 levels to the
cytosol after E3. Depletion of p35 from the membrane correlated with reduced phosphorylation
of the Cdk5 substrate PAK-1, indicating that extinction leads to reduced membrane-associated
Cdk5 activity. Our data suggests that membrane depletion of p35 is a mechanism for locally
reducing Cdk5 activity, and thereby allowing extinction to occur.
Previous reports showed that the small GTPase Rac-1 binds p35, thereby affecting the
subcellular distribution of Cdk5 activity15,36. Moreover, Rac-1 activity has been implicated
in synaptic plasticity27. Therefore, we investigated the role of Rac-1 during Cdk5-dependent
extinction. Notably, we found that extinction led to a reduction of membrane-associated GTP-
bound Rac-1 after E3 without affecting the total amount of Rac-1 protein, suggesting a
reduction in Rac-1 activity. The fact that reductions of membrane-associated Rac-1 and Cdk5
activity after E3 occurred simultaneously indicates that Rac-1 and Cdk5 might be part of the
same signaling pathway during extinction. In support of this notion, inhibition of Rac-1 activity
reduced the levels of membrane-associated p35 protein, thereby recapitulating the cellular
changes observed after E3 when freezing behavior declined during physiological extinction.
Notably, when Rac-1 activity was inhibited during extinction, we observed a redistribution of
both p35 and Cdk5 from the membrane to the cytosol, whereas only p35 was affected during
physiological extinction. As our data indicate that Rac-1 activity regulates extinction via Cdk5/
p35 kinase, it is plausible that pharmacological inhibition of Rac-1 causes more marked
changes on the molecular level than the alterations that occur during extinction under
physiological conditions. Taken together, our data suggest that Rac-1 and Cdk5/p35 kinase are
part of a distinctive signaling pathway that prevents extinction under physiological conditions.
Cdk5 directly phosphorylates PAK-1 on threonine 212 and inhibits PAK1 activity. Our
observations that PAK-1T212 levels decreased during extinction suggest that PAK-1 activity
might be upregulated. Consistent with this assumption, we found that phosphorylation of
membrane-associated PAK-1 at the non-Cdk5 site threonine 423 was increased after E3. The
autophosphorylation of threonine 423 of PAK-1 liberates the Pak-1 inhibitory domain and is
a marker for active PAK-1 (refs. 28,37). Cytosolic PAK-1T423 levels decreased after E1, but
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increased back to baseline after E3. These findings suggest that the reduction of aversive
freezing behavior correlates with increased PAK-1 activity.
Notably, we found that inhibition of Rac-1 and Cdk5 activity during extinction reduced
PAK-1T212 levels, providing direct evidence that Rac-1 and Cdk5 regulate PAK-1 through
threonine 212 phosphorylation during extinction. Also, inhibition of Cdk5 led to increased
PAK-1T423 levels. These data suggest that Cdk5 activity regulates PAK-1 during extinction.
Inhibition of Rac-1 and Cdk5 also induced a redistribution of PAK-1 from the membrane to
the cytosol. This is consistent with previous findings demonstrating that Cdk5 activity affects
the subcellular localization of PAK-1 in neuronal growth cones36. However, despite increased
cytosolic p35 and Cdk5 levels, there was no corresponding increase in the phosphorylation of
PAK-1 on threonine 212 in the cytosol. It was actually reduced. We speculate that this could
be due to the fact that p35 is sequestered from PAK-1 on redistribution to the cytosol, because
the p35–PAK-1 interaction, independent of phosphorylation, has been implicated with
inhibition PAK-1 activity36. Indeed, we found that less p35 co-immunoprecipitated with
PAK-1 in hippocampal lysates prepared from mice injected with the Rac-1 inhibitor when
compared with the vehicle group.
In summary, our data indicate that during extinction membrane depletion of Cdk5 activity and
dissociation of p35 from PAK-1 in the cytosol removes the inhibitory tone on PAK-1 activity.
This eventually results in an increase of mainly cytosolic PAK-1 activity. It is likely that PAK-1
activity during extinction is regulated by additional mechanisms, such as protein phosphatases.
In fact, protein phosphatase 1 has been implicated in extinction processes43. We provide direct
evidence that PAK-1 activity is required for extinction, as inhibition of PAK-1 by viral-
mediated hippocampal expression of a dominant-negative PAK-1 mutant substantially
impaired extinction. As such, the effect of PAK-1 inhibition on extinction is opposite to that
of Rac-1 and Cdk5 inhibition. This finding supports the idea that RAC-1, Cdk5/p35 kinase and
PAK-1 are counteracting components of a hippocampal signaling pathway that regulates
extinction of contextual fear. When taken together, our data delineate a molecular pathway
whereby extinction requires the downregulation of Rac-1 and Cdk5, and the upregulation of
PAK-1 activity. Notably, Rac-1, Cdk5/p35 kinase and PAK-1 have all been implicated in the
regulation of the actin cytoskeleton15.
Remodeling of synaptic circuits via actin dynamics is an important molecular mechanism
during the acquisition and extinction of fear. For example, actin dynamics regulate spine
morphology, synaptogenesis12,44 and hippocampal long-term potentiation11. Moreover, a
dynamic actin cytoskeleton is required for extinction6. In fact, recent data suggest that
remodeling of synaptic circuits via actin dynamics is an important molecular mechanism during
extinction3,6. PAK-1 phosphorylates LIM-kinase45, which in turn regulates the actin-binding
protein cofilin46. This suggests the intriguing possibility that a Rac-1–Cdk5/p35–PAK-1
pathway affects the dynamics of the actin cytoskeleton, thereby affecting neuronal
morphology. Consistent with this assumption, it should be noted that increased Cdk5 activity
has been implicated with the formation and strengthening of new synapses19, whereas
decreased Cdk5 activity is associated with a reduced number of dendritic spines19,47. The
possibility arises that the observed redistribution of Cdk5 activity during extinction allows for
synaptic remodeling via actin dynamics. Cdk5 activity likely regulates extinction via multiple
mechanisms. For example, deletion of Cdk5 in the hippocampus was recently shown to
facilitate the extinction of contextual fear via NMDA receptor–mediated synaptic
transmission26.
Our findings provide evidence that, in addition to mechanisms that promote extinction,
strategies that impair extinction have evolved as molecular counter players. In fact, the Rac-1–
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Cdk5–PAK-1 signaling pathway described here may provide an example whereby pathways
that impair and promote extinction are mechanistically linked. From an evolutionary point of
view, mechanisms that impair extinction seem reasonable, as rapid extinction of fear after
exposure to threatening situations, such as places where a predator attacked, could be
disadvantageous for survival. In fact, in contrast to other experimental procedures, where
extinction sometimes occurs in a single trial48, in the fear-conditioning procedure employed
in this study, extinction only occurs after 4–6 extinction trials. This is consistent with the fact
that patients suffering from emotional disorders such as phobia usually require multiple
exposure sessions before the aversively motivated behavior is extinguished4. As such,
molecular mechanisms that impair extinction, such as Rac-1 and Cdk5 activity, could be
promising drug targets for emotional disorders.
METHODS
Animals
Mice (Balb/c, 12 weeks old) were housed under standard conditions with access to food and
water ad libitum. All mice were purchased from Taconic. As this is a collaborative study, we
should mention that behavior testing was carried out in such a way that the mice were either
housed in a separated compartment in the testing room, or different rooms were used for
housing and testing. In the latter case, the mice were brought to the testing room before the
procedure. Although it appears that the dynamics of extinction behavior are somewhat variable
depending on the employed behavior facility, the trends remained the same in different
experiments. All experiments were approved by the Institutional Animal Care and Use
Committees of Harvard University, Massachusetts Institute of Technology and Northwestern
University.
Extinction of contextual freezing behavior
Extinction and reminder shock procedures were carried out as described previously6. In brief,
mice were exposed to contextual fear conditioning (3 min context followed by at mild electric
foot shock, 2 s, 0.7 mA). In some experiments, a tone (30 s, 10 kHz, 75 dB sound pressure
level) was presented for 30 s before the shock. Extinction was carried out on consecutive days.
An extinction trial consisted of a 3 min re-exposure to the conditioning context. In our
procedure, substantial reduction of freezing was observed during E4. However, we found that
this time course strongly depended on the experimental setting.
Surgery and injections
Custom-made microcannula were purchased from PlasticOne. The gauges of the guide and
injection cannula were 26 and 28, respectively. To insert cannula into the dorsal hippocampus,
we used the coordinates anterior-posterior −1.5 mm, lateral 1 mm, depth 2 mm as described
previously18. To insert cannula intracerebroventricular (ICV), we used the coordinates AP
+0.5 mm, lateral 1 mm, depth 2 mm. Butyrolactone I and roscovitine were dissolved and
injected as described previously18. Rac-1 inhibitor was dissolved in artificial cerebrospinal
fluid and delivered bilaterally (0.5 μl per side) over a 1-min period. The correct localization of
the cannula was verified at the end of an experiment by methylene blue injection. The cistronic
herpes virus expressing GFP and dnPAK-1 or GFP alone was injected into the hippocampus
bilaterally (0.5 μl per side) over a 2-min period. dnPAK-1 was a gift from S. Tonegawa
(Massachusetts Institute of Technology), and consisted of the DNA encoding amino acid 83–
149 of PAK-1. It has been previously demonstrated that this fragment acts as a dominant-
negative protein toward Pak-1 and impairs PAK-1 activity in vitro and in vivo28.
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Immunoblot analysis
Immunoblot analysis was performed as described previously 19. The antibody detecting
pPAK-1Thr212 was a gift from M. Nikolic (Imperial College London) and used in a 1:250
dilution. Antibody to PAK-1 was from Santa Cruz. All other antibodies were used in a 1:1,000
dilution: pPAK-1Thr423 (Cell Signaling), synaptophysin (Sigma), GAPDH and Rac-1
(Upstate), Cdk5 (J3, Santa Cruz) and p35 (C-19, Santa Cruz).
Immunohistochemistry
Immunohistochemical analyses were carried out as described previously19. Antibodies were
used in a 1:1,000 concentration: GFP (Molecular Probes) and NeuN (Chemicon).
Statistical analysis
The data were analyzed by unpaired Student’s t-test. We employed one-way ANOVAs,
followed by post hoc Scheffe’s test to compare means from several groups at the same time.
Data are presented as s.e.m. A detailed description of the statistics employed in this study can
be found in ref. 49.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Inhibition of hippocampal Cdk5 activity facilitates extinction. (a) Mice (ten per group) were
subjected to our extinction procedure and injected (intrahippocampal) with butyrolactone I (50
ng) immediately after E1–E3. When compared with the vehicle group, butyrolactone I–injected
mice showed reduced freezing behavior on E2 and E3, indicating facilitated extinction. (b)
The experiment was carried out as described in a, but a lower concentration (25 ng) of
butyrolactone I was injected after E1–E3. Extinction was similar in vehicle and butyrolactone
I–injected mice. (c) Similar results were obtained when mice were administered 12.5 ng of
butyrolactone I. (d) Consistent with the data shown in a, a single injection of 50 ng of
butyrolactone immediately after E1 facilitated extinction, as indicated by a significant
reduction of freezing behavior on E2 when compared with a vehicle group. The reduced
freezing behavior persisted throughout extinction trials in the absence of further butyrolactone
I injection. (e) Mice were subjected to our extinction procedure and injected with butyrolactone
I (50 ng) 1 h after E1. This facilitated extinction, as indicated by a significant reduction of
freezing behavior on E2 when compared with a vehicle group. (f) Intrahippocampal injection
of butyrolactone I 3 h after E1 had no significant effect on extinction when compared with the
vehicle group. *P < 0.05 versus vehicle group, n = 9–10 mice per group. Error bars represent
s.e.m.
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Figure 2.
Increased Cdk5 activity in CK-p25 Tg mice impairs extinction. (a) Experimental design. CK-
p25 Tg (n = 9) and control mice (n = 9) were trained by contextual fear conditioning, and p25
expression was induced 24 h later for 1 week. Afterwards, all mice were exposed to six
extinction trials before repression of p25 production in CK-p25 Tg by reintroduction of
doxycycline to the diet. After 1 week, all mice were subjected to another five extinction trials
on consecutive days. (b) Immunoblot analysis of hippocampal lysates from CK-p25 Tg and
control mice. Antibody to p35 (C-19) was employed to detected endogenous p25 and p25-GFP
in CK-p25 Tg mice 1 week after p25 induction and 1 week after p25 repression, respectively.
(c) Cdk5 kinase activity was analyzed by p35 (C-19) immunoprecipitation assays using histone
H1 as an in vitro substrate. Cdk5 activity was significantly increased after 1 week of induction,
and decreased to baseline levels after 1 week of p25 repression. (d) CK-p25 Tg and control
mice were subjected to the experimental procedure described in a. As long as p25 was
expressed in CK-p25 Tg, leading to increased Cdk5 activity, the extinction of freezing behavior
was abolished. When p25 production was repressed and Cdk5 activity was reduced to baseline
levels, extinction occurred in the same mice. ***P < 0.0001, n = 3–5 for biochemical analysis.
Error bars represent s.e.m.
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Figure 3.
Membrane association of Cdk5 and p35 during extinction is regulated by Rac-1. (a) Membrane
and cytosolic fractions were prepared from the hippocampus of mice 0.5 h after exposure to
E1, E3 or from naive animals. We observed a significant reduction of membrane-associated
p35 that was accompanied by increased cytosolic p35 levels after E3. Synaptophysin (SVP)
served as a loading control for the membrane fraction, whereas GAPDH was employed to
verify equal loading in the cytosolic fraction. (b) Membrane lysates prepared from mice 0.5 h
after E3 and from naive mice were used in a Rac-1 kinase assay. Rac-1 activity was significantly
decreased after E3. (c) Hippocampal cytosolic and membrane fractions were prepared on E3
0.5 h after mice were injected (ICV) with either vehicle or Rac-1 inhibitor. Immunoblot analysis
showed a significant reduction of membrane-associated Cdk5/p35 when compared with
vehicle-injected mice. (d) Consistent application of Rac-1 inhibitor facilitated extinction. Mice
(10 per group) were subjected to our extinction procedure and injected (ICV) with Rac-1
inhibitor (NSC23760; 10 μg μl−1) immediately after E1–E3. When compared with the vehicle
group, Rac-1 inhibitor injected mice showed reduced freezing, indicating facilitated extinction.
n = 3–5 for biochemical analysis. ***P < 0.0001 versus naive/vehicle group, *P < 0.05 versus
naive/vehicle group. Error bars represent s.e.m.
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Figure 4.
Inhibition of Rac-1 facilitates extinction. (a) Membrane and cytosolic fractions were prepared
from the hippocampus of mice 0.5 h after exposure to E1, E3 or from naive animals and
analyzed for PAK-1 by immunoblotting. Levels of PAK-1Thr212 were significantly decreased
in the membrane fraction after E3. (b) The same lysates as in a were used to analyze the levels
of pPAK-1T423, a non-Cdk5 phosphorylation site that indicates active PAK-1. pPAK-1T423
levels were significantly increased after E3 in the membrane fraction. In the cytosolic fraction,
pPAK-1T423 levels decreased after E1 when compared with naive mice, but increased back to
baseline levels after E3. (c) Hippocampal cytosolic and membrane fractions were prepared on
E3 0.5h after mice were injected (ICV) with either vehicle or Rac-1 inhibitor. Immunoblot
analysis showed a significant reduction of membrane-associated p35/Cdk5, pPAK-1T212 and
PAK-1 levels. (d) The same lysates as described in c were used to immunoprecipitate PAK-1.
A hemagglutinin antibody served as a control for nonspecific binding of proteins to the protein
A–agarose beads. The precipitates were immunoblotted with antibodies to PAK-1 and p35.
There was a substantial reduction in the amount of p35 that co-immunoprecipitated with PAK-1
in lysates from mice that were administered with Rac-1 inhibitor. Error bars represent s.e.m.
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Figure 5.
Cdk5 affects PAK-1 activity during extinction. (a) Experimental design. Microcannula were
implanted into the hippocampus of mice that were subjected to contextual fear conditioning.
The Cdk5 inhibitor butyrolactone I (50 ng) was injected immediately after exposure to E1 and
hippocampal cytosolic and membrane fractions were prepared 0.5 h later. (b) Mice injected
with butyrolactone I (But) showed significantly reduced levels of PAK-1T212 in the cytosolic
fraction. (c) Similarly, PAK-1T212 levels were reduced in the membrane fraction. Conversely,
levels of pPAK-1T423 were significantly increased. (d) Notably, butyrolactone-injected mice
also showed a significant redistribution of PAK-1 from the membrane to the cytosol when
compared with vehicle-injected mice. Error bars represent s.e.m.
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Figure 6.
PAK-1 activity promotes extinction. (a) Experimental design. Mice were implanted with
microcannula in the dorsal hippocampus and subjected to contextual fear conditioning. After
24 h, mice were injected with either HSV-GFP or HSV-GFP– dnPAK-1 virus into the dorsal
hippocampus. As of the next day, all mice were subjected to our extinction procedure. (b)
Herpes virus expressing GFP and a dnPAK-1 construct or only GFP were injected into the
dorsal hippocampus of mice. Upper, DAB staining for GFP of mice injected with dnPAK-1–
GFP. Lower, high-magnification pictures of the hippocampal region showing staining for
Hoechst, NeuN and GFP. The transfection efficiency was about 30%. Analysis was carried out
48 h after injection. (c) Mice (n = 10 per group) expressing dnPAK-1 in the hippocampus show
a significantly impaired reduction of freezing behavior indicating impaired extinction. Error
bars represent s.e.m.
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